Company Filing History:
Years Active: 2025
Title: Amanda J Stock: Innovator in Peptide Therapeutics for Alzheimer's Disease
Introduction
Amanda J Stock is a prominent inventor based in Nottingham, MD (US). She has made significant contributions to the field of peptide therapeutics, particularly in the treatment of Alzheimer's disease and related conditions. Her innovative work focuses on developing peptide compounds that can inhibit the harmful effects of amyloid β peptide, which is associated with neurodegenerative diseases.
Latest Patents
Amanda J Stock holds a patent for "Peptide therapeutics for treating Alzheimer's disease and related conditions." This patent includes peptide compounds derived from cathepsin G, neutrophil elastase, and cationic antimicrobial protein of 37 kDa. The methods disclosed in her patent aim to inhibit and/or reverse the polymerization of amyloid β peptide into oligomers and fibrils. Additionally, her work addresses the disaggregation of amyloid β plaques and explores the use of these peptide compounds in treating Alzheimer's disease, cerebral amyloid angiopathy, dementia, and neuroinflammation.
Career Highlights
Amanda is affiliated with the University of Oklahoma, where she continues her research and development in peptide therapeutics. Her dedication to advancing medical science has positioned her as a key figure in the fight against Alzheimer's disease.
Collaborations
Amanda has collaborated with notable colleagues, including Anne Kasus-Jacobi and Heloise Anne Pereira. These partnerships enhance her research efforts and contribute to the broader scientific community's understanding of neurodegenerative diseases.
Conclusion
Amanda J Stock's innovative work in peptide therapeutics represents a significant advancement in the treatment of Alzheimer's disease. Her contributions are vital in the ongoing quest to find effective therapies for neurodegenerative conditions.